Canadian Agency for Drugs and Technologies in Health
CADTH is a national organization whose stated mission is to provide "Canada’s federal, provincial and territorial health care decision makers with credible, impartial advice and evidence-based information about the effectiveness and cost-effectiveness of drugs and other health technologies". Before April 2006, CADTH was known as the Canadian Coordinating Office for Health Technology Assessment (CCOHTA).[1] CADTH celebrated its 25th anniversary in 2014.
Organization
CADTH is the home of several health technology assessment (HTA) programs and services, namely:
- Common Drug Review (CDR)
- Pan-Canadian Oncology Drug Review (pCODR)
- Optimal Use of Drugs and Devices
- Environmental and Horizon Scanning
- Rapid Response Service
CADTH is funded by the federal, provincial and territorial governments, with the exception of Quebec.
CADTH also acts as secretariat for the following groups:
- Policy Forum
- Health Technology Analysis Exchange
- Pharmaceutical Directors' Forum
Location
The main offices of CADTH are located in Ottawa, Ontario. There is also an office in Edmonton, Alberta, and Toronto, Ontario. In addition, individual Liaison Officers are located in most provinces.
See also
- International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH)
- Food and Drug Administration (FDA, USA)
- European Medicines Agency (EMEA, EU)
- Ministry of Health, Labour and Welfare (Japan)
- Health Canada
References
- ↑ http://www.cadth.ca"CADTH Home Page", 1 April 2015, accessed 23 April 2015